Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis
Kamanamool N, McEvoy M, Attia J, Ingsathit A, Ngamjanyaporn P, Thakkinstian A
 
 
Record Status
This is a systematic review that meets the criteria for inclusion on DARE.
Bibliographic details
Kamanamool N, McEvoy M, Attia J, Ingsathit A, Ngamjanyaporn P, Thakkinstian A. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis. Medicine 2010; 89(4) : 227-235
PubMedID
20616662
DOI
10.1097/MD.0b013e3181e93d00
Original Paper URL
http://journals.lww.com/md-journal/Abstract/2010/07000/Efficacy_ and_ Adverse_ Events_ of_ Mycophenolate.5.aspx
Indexing Status
Subject indexing assigned by NLM
MeSH
Cyclophosphamide /adverse effects /therapeutic use; Humans; Immunosuppressive Agents /adverse effects /therapeutic use; Lupus Nephritis /complications /drug therapy; Mycophenolic Acid /adverse effects /analogs & Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; derivatives /therapeutic use
AccessionNumber
12010005705
Date bibliographic record published
14/09/2011
 
Database of Abstracts of Reviews of Effects (DARE)
Produced by the Centre for Reviews and Dissemination
Copyright © 2026 University of York
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for DARE database users